The effect of 15-Lipoxygenase-1 expression on cancer cells (original) (raw)

• Smith WL, Garavito RM, DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996, 271:33157–33160.
  Article CAS PubMed Google Scholar
• Ghosh J, Myers CE: Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 1997, 235:418–423.
  Article CAS PubMed Google Scholar
• Gao X, Grignon DJ, Chbihi T, et al.: Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology 1995, 46:227–237.
  Article CAS PubMed Google Scholar
• Spindler SA, Sarkar FH, Sakr WA, et al.: Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines. Biochem Biophys Res Commun 1997, 239:775–781.
  Article CAS PubMed Google Scholar
• Kelavkar UP, Cohen C, Kamitani H, et al.: Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging. Carcinogenesis 2000, 10:1777–1787. This study represents the first assessment of 15-LO-1 overexpression in human prostate cancer tissue of different Gleason grades compared with normal surrounding tissue.
  Article Google Scholar
• Shappell SB, Boeglin WE, Olson SJ, et al.: 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. Am J Pathol 1999, 155:235–245. The authors examined the prevalence of 15-LO-2 expression in normal human prostate tissue compared with adenocarcinoma tissues.
  CAS PubMed Google Scholar
• Reddy N, Everhart A, Eling T, Glasgow W: Characterization of a 15-lipoxygenase in human breast carcinoma: BT-20 cells: stimulation of 13-HODE formation by TGF alpha/EGF. Biochem Biophys Res Commun 1997, 231:111–116.
  Article CAS PubMed Google Scholar
• Kelavkar U, Badr K: Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene. Proc Natl Acad Sci U S A 1999, 96:4378–4783.
  Article CAS PubMed Google Scholar
• Navone NM, Labate ME, Troncoso P, et al.: p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential. J Urol 1999, 161:304–308.
  Article CAS PubMed Google Scholar
• Kelavkar UP, Nixon J, Cohen C, et al.: Overexpression of 15-lipoxygenase-1 (15-LO-1) in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis 2001, 22:1765–1773. This in vivo study demonstrated that 15-LO-1 overexpression in prostate cancer PC-3 cells caused rapid and enhanced tumorigenesis compared with parental PC-3 cells, and also suggests that 15-LO-1 overexpression may be angiogenic.
  Article CAS PubMed Google Scholar
• Zock PL, Katan MB: Linoleic acid intake and cancer risk: a review and meta-analysis. Am J Clin Nutr 1998, 68:142–153.
  CAS PubMed Google Scholar
• Cesano A, Visonneau S, Scimeca JA, et al.: Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res 1998, 18:1429–1434.
  CAS PubMed Google Scholar
• Kamitani H, Geller M, Eling T: Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation. J Biol Chem 1998, 273:21569–21577.
  Article CAS PubMed Google Scholar
• Ikawa H, Kamitani H, Calvo BF, et al.: Expression of 15-lipoxygenase-1 in human colorectal cancer. Cancer Res 1999, 59:360–366.
  CAS PubMed Google Scholar
• Shureiqi I, Wojno KJ, Poore JA, et al.: Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 1999, 20:1985–1995.
  Article CAS PubMed Google Scholar
• Shureiqi I, Chen D, Lee JJ, et al.: 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Nat Cancer Inst 2000, 92:1136–1142.
  Article CAS PubMed Google Scholar
• Hsi LC, Wilson L, Nixon J, Eling TE: 15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway. J Biol Chem 2001, 276:34545–34552. The paper critically assesses the efficacy of 13-(S)-HODE to be protumorigenic in colorectal cancer cells by modulating the antitumorigenic PPARγ activity.
  Article CAS PubMed Google Scholar
• Wechter WJ, Leipold DD, Murray ED, et al.: E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Cancer Res 2000, 60:2203–2208.
  CAS PubMed Google Scholar
• Shappell SB, Gupta RA, Manning S, et al.: 15-S-hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res 2001, 61:497–503. The authors demonstrated, for the first time, that the 15-LO-2 and arachidonic acid metabolic product 15-(S)-HETE inhibited the growth of prostate cancer cell line PC-3 via activation of antitumorigenic PPARγ activity.
  CAS PubMed Google Scholar
• Shappell SB, Manning S, Boeglin WE, et al.: Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma. Neoplasia 2001, 3:287–303.
  Article CAS PubMed Google Scholar
• Tang S, Bhatia B, Maldonado CJ, et al.: Evidence that arachidonate 15-lipoxygenase 2 is a negative cell-cycle regulator in normal prostate epithelial cells. J Biol Chem 2002, in press.
• Baserga R, Resnicoff M, Dews M: The IGF-I receptor and cancer. Endocrine 1997, 1:99–102.
  Article Google Scholar
• Parrizas M, Saltiel AR, LeRoith D: Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem 1997, 272:154–161.
  Article CAS PubMed Google Scholar
• Werner H: Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression. Mol Cell Endocrinol 1998, 141:1–5.
  Article CAS PubMed Google Scholar
• DiGiovanni J, Kiguchi K, Frijhoff A, et al.: Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci U S A 2000, 97:3455–3460. The authors provide an excellent mouse model of IGF-1 deregulation causal in prostate cancer.
  Article CAS PubMed Google Scholar
• DiGiovanni J, Bol DK, Wilker E, et al.: Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res 2000, 60:1561–1570.
  CAS PubMed Google Scholar
• Kamitani H, Taniura S, Ikawa H, et al.: Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. Carcinogenesis 2001, 22:187–191.
  Article CAS PubMed Google Scholar
• Shureiqi I, Chen D, Lotan R, et al.: 15-lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res 2000, 60:6846–6850.
  CAS PubMed Google Scholar
• Sarraf P, Mueller E, Jones D, et al.: Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med 1998, 4:1046–1052.
  Article CAS PubMed Google Scholar
• Nagy L, Tontonoz P, Alvarez JG, et al.: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93:229–240.
  Article CAS PubMed Google Scholar
• Glasgow WC, Afshari CA, Barrett JC, Eling TE: Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts: differential effects in tumor suppressor gene (+) and (-) phenotypes. J Biol Chem 1992, 267:10771–10779.
  CAS PubMed Google Scholar
• Glasgow WC, Hui R, Jayawickreme S, et al.: 13(S)-HpODE augments epidermal growth factor signal transduction by attenuating EGF receptor dephosphorylation. Adv Exp Med Biol 1999, 469:371–375.
  CAS PubMed Google Scholar
• Camp HS, Tafuri SR: Regulation of peroxisome proliferatoractivated receptor gamma activity by mitogen-activated protein kinase. J Biol Chem 1997, 272:10811–10816.
  Article CAS PubMed Google Scholar
• Natarajan R, Nadler J: Role of lipoxygenases in breast cancer. Front Biosci 1998, 8:81–88.
  Google Scholar
• Glasgow WC, Eling TE: Epidermal growth factor stimulates linoleic acid metabolism in BALB/c 3T3 fibroblasts. Mol Pharmacol 1990, 38:503–510.
  CAS PubMed Google Scholar
• Glasgow WC, Eling TE: Structure-activity relationship for potentiation of EGF-dependent mitogenesis by oxygenated metabolites of linoleic acid. Arch Biochem Biophys 1994, 311:286–292.
  Article CAS PubMed Google Scholar
• Angerman-Stewart JA, Eling TE, Glasgow WC: Prostaglandin H synthase-2 is induced in Syrian hamster embryo cells in response to basic fibroblast growth factor. Arch Biochem Biophys 1995, 318:378–386.
  Article CAS PubMed Google Scholar
• Glasgow WC, Hill EM, McGown SR, et al.: Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase. Mol Pharmacol 1996, 49:1042–1048.
  CAS PubMed Google Scholar
• Hui R, Everhart AL, Glasgow WC: Epidermal growth factorstimulated production of esterified 13(S)-hydroxyoctadecadienoic acid is associated with tumor suppressor phenotype in Syrian hamster embryo fibroblasts. J Lipid Res 1997, 38:49–60.
  CAS PubMed Google Scholar
• Glasgow WC, Hui R, Everhart AL, et al.: The linoleic acid metabolite, 13(S)-hydroxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. J Biol Chem 1997, 272:19269–19276.
  Article CAS PubMed Google Scholar
• Lupu R, Lippman ME: The role of erbB2 signal transduction pathways in human breast cancer. Breast Cancer Res Treat 1993, 27:83–93.
  Article CAS PubMed Google Scholar
• Jardines L, Weiss M, Fowble B, Greene M: neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer. Pathobiol 1993, 61:268–282.
  Article CAS Google Scholar
• Rose DP, Connolly JM, Liu XH: Dietary fatty acids and human breast cancer cell growth, invasion, and metastasis. In Diet and Breast Cancer. Edited by the American Institute for Cancer Research. New York: Plenum Press; 1994:83–91.
  Google Scholar
• Rose DP: Dietary fat and breast cancer: controversy and biological plausibility. In Diet and Breast Cancer. Edited by the American Institute for Cancer Research. New York: Plenum Press; 1994:1–10.
  Google Scholar
• Koi M, Barrett JC: Loss of tumor suppressor function during chemically induced neoplastic progression of Syrian hamster embryo cells. Proc Natl Acad Sci U S A 1986, 83:5992–5996.
  Article CAS PubMed Google Scholar
• Hui R, Kameda H, Risinger JI, et al.: The linoleic acid metabolite 13-HpODE augments the phosphorylation of EGF receptor and SHP-2 leading to their increased association. Prostaglandins Leukot Essent Fatty Acids 1999, 61:137–143.
  Article CAS PubMed Google Scholar
• Kameda H, Risinger JI, Han B, et al.: Identification of epidermal growth factor receptor-Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic progression. Cell Growth Differ 1999, 12:307–318.
  Google Scholar
• Feng GS, Hui CC, Pawson T: SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 1993, 259:1607–1611.
  Article CAS PubMed Google Scholar
• Sugimoto S, Lechleider RJ, Shoelson SE, et al.: Expression, purification, and characterization of SH2-containing protein tyrosine phosphatase, SH-PTP2. J Biol Chem 1993, 268:22771–22776.
  CAS PubMed Google Scholar